Lipid Metabolism Practice Questions

Q: Which of the following is an ω-6 fatty acid?

Linoleic acid. ***Linoleic acid*** - **Linoleic acid** (LA), an 18-carbon fatty acid with two double bonds (18:2), is classified as an **ω-6 fatty acid** because its first double bond is located at the sixth carbon atom from the methyl end of the fatty acid chain. - It is an **essential fatty acid** that must be obtained through diet, serving as a precursor for other ω-6 fatty acids like arachidonic acid. *Cervonic acid* - **Cervonic acid** is another name for **docosahexaenoic acid (DHA)**, which is an **ω-3 fatty acid** (22:6). - Its first double bond is located at the third carbon from the methyl end. *Alpha linolenic acid* - **Alpha-linolenic acid** (ALA) is an **ω-3 fatty acid** (18:3). - Its first double bond is located at the third carbon atom from the methyl end. *Elaidic acid* - **Elaidic acid** is a **trans fatty acid** (18:1 trans-9). - It is classified as an **ω-9 fatty acid** due to the position of its double bond, but its trans configuration is the primary distinguishing feature.

Q: Enzyme deficient in Type I Hyperlipidemia?

Lipoprotein lipase. ***Lipoprotein lipase*** - **Type I hyperlipidemia**, also known as **familial hyperchylomicronemia**, is characterized by a deficiency in **lipoprotein lipase (LPL)**. - LPL is crucial for hydrolyzing triglycerides in **chylomicrons** and **VLDLs** into fatty acids and glycerol, allowing their uptake by tissues. *HMG CoA reductase* - This enzyme is involved in the **rate-limiting step of cholesterol synthesis** in the liver. - While it plays a role in lipid metabolism, its deficiency is not characteristic of **Type I hyperlipidemia**. *Peroxidase* - **Peroxidase** is an enzyme involved in various oxidative reactions, including the breakdown of **hydrogen peroxide**. - It is not directly involved in the metabolism of **chylomicrons** or **triglycerides**, and its deficiency is unrelated to hyperlipidemia. *Cholesterol acyl transferase* - This enzyme, often referring to **lecithin-cholesterol acyltransferase (LCAT)** or **acyl-CoA:cholesterol acyltransferase (ACAT)**, is involved in **cholesterol esterification**. - While important for cholesterol transport and storage, its deficiency is not the primary cause of **Type I hyperlipidemia**, which is marked by severe **chylomicronemia**.

Q: Which of the following is monoenoic acid ?

Oleic acid. ***Oleic acid*** - **Oleic acid** is a **monounsaturated fatty acid** (MUFA), meaning it has **one double bond** in its hydrocarbon chain. - Its presence in many natural fats and oils makes it a significant component of the human diet. *Arachidonic acid* - **Arachidonic acid** is a **polyunsaturated fatty acid** (PUFA) containing **four double bonds**. - It is a precursor for **eicosanoids**, including prostaglandins and leukotrienes, involved in inflammation and other physiological processes. *Linoleic acid* - **Linoleic acid** is an **essential omega-6 polyunsaturated fatty acid** with **two double bonds**. - It is crucial for human health and serves as a precursor for other fatty acids like arachidonic acid. *Linolenic acid* - **Linolenic acid** refers to two essential fatty acids: **alpha-linolenic acid (ALA)**, an omega-3 fatty acid with **three double bonds**, and **gamma-linolenic acid (GLA)**, an omega-6 fatty acid also with three double bonds. - Both are **polyunsaturated fatty acids** with multiple double bonds.

Q: Which of the following is a true difference between gangliosides and cerebrosides?

Charge difference. ***Charge difference*** - **Gangliosides** contain **sialic acid (N-acetylneuraminic acid)** residues, which are negatively charged, making gangliosides **anionic**. - **Cerebrosides** are **neutral glycosphingolipids** as they lack charged sugar residues. *Specific carbohydrate composition* - While both have carbohydrate components, referring to "specific carbohydrate composition" as the *true difference* is too broad. Both have characteristic sugar groups, but the **presence of sialic acid** in gangliosides is the key differentiator in charge. - Cerebrosides typically contain a single sugar (either glucose or galactose), whereas gangliosides have a more complex oligosaccharide chain including sialic acid. *Presence of glucose* - Both cerebrosides (specifically **glucocerebrosides**) and gangliosides can contain **glucose** in their carbohydrate moieties. - This is not a distinguishing feature; the *type* and *arrangement* of sugars, particularly the presence of sialic acid, are more specific. *Location in the nervous system* - Both gangliosides and cerebrosides are abundant in the **nervous system**, particularly in cell membranes. - Their presence in the nervous system is a similarity, not a differentiating factor.

Q: Apo-E deficiency is seen in which of the following conditions?

Type III hyperlipoproteinemia. ***Type III hyperlipoproteinemia*** - This condition, also known as **familial dysbetalipoproteinemia** or **broad beta disease**, is characterized by a deficiency or abnormal function of **apolipoprotein E (apoE)**. - The deficiency in functional apoE impairs the clearance of **chylomicron remnants** and **intermediate-density lipoproteins (IDLs)** from the blood. *Type II hyperlipoproteinemia* - This condition primarily involves elevated **LDL cholesterol** and is often due to defects in the **LDL receptor** or mutations in **apoB-100**, not apoE deficiency. - It does not directly involve the impaired clearance of chylomicron remnants or IDLs. *Type I hyperlipoproteinemia* - Also known as **familial chylomicronemia syndrome**, this condition is characterized by severe elevation of **chylomicrons** and **triglycerides**. - It is caused by a deficiency of **lipoprotein lipase (LPL)** or its cofactor **apoC-II**, not apoE. *Type IV hyperlipoproteinemia* - This condition, also known as **familial hypertriglyceridemia**, is characterized by abnormally high levels of **very-low-density lipoproteins (VLDL)** and **triglycerides**. - It is typically caused by increased VLDL production or impaired VLDL clearance, but not directly due to an apoE deficiency.

Q: Which molecule serves as the ultimate source of acetyl groups for fatty acid synthesis?

Acetyl CoA. ***Acetyl CoA*** - **Acetyl CoA** is the ultimate source of all acetyl groups used in fatty acid synthesis - It serves as the substrate for **acetyl CoA carboxylase**, which converts it to **malonyl CoA** - After transport from mitochondria via **citrate**, acetyl CoA is the precursor for all two-carbon units incorporated into fatty acids - One molecule of acetyl CoA also serves as the primer for fatty acid synthesis *Malonyl CoA* - **Malonyl CoA** is the direct two-carbon donor to the growing fatty acid chain - However, it is derived from **acetyl CoA** through carboxylation by **acetyl CoA carboxylase** - It is an intermediate, not the ultimate source of acetyl groups *Palmitate* - **Palmitate** is a 16-carbon saturated fatty acid that is the end product of de novo fatty acid synthesis - It is the product of fatty acid synthesis, not a donor of acetyl groups *Citrate* - **Citrate** transports acetyl groups from the **mitochondria** to the **cytosol** where fatty acid synthesis occurs - In the cytosol, **ATP citrate lyase** cleaves citrate back into **acetyl CoA** and oxaloacetate - Citrate is a transport vehicle, not the ultimate source of acetyl groups

Q: Why is oxidized LDL considered more atherogenic?

Is taken up by scavenger receptors. ***Is taken up by scavenger receptors*** - **Oxidized LDL (oxLDL)** is taken up by **scavenger receptors (CD36, SR-A)** on macrophages, which have **no feedback regulation**. - Unlike native LDL receptors that downregulate when cells have sufficient cholesterol, **scavenger receptors continue unlimited uptake**, leading to foam cell formation. - This **unregulated uptake mechanism** is the key reason why oxLDL is **more atherogenic** than native LDL. - The result is lipid-laden macrophages forming **fatty streaks**, the initial lesions of **atherosclerosis**. *Is not recognized by LDL receptors* - While true that oxLDL has **reduced affinity** for native LDL receptors due to oxidative modification, this alone doesn't explain increased atherogenicity. - The critical factor is what happens instead—its uptake via an **alternative, unregulated pathway**. *Accumulates in macrophages* - This is a **consequence** of scavenger receptor uptake, not the primary mechanism. - Foam cell formation occurs **because** of unregulated scavenger receptor uptake, making this a downstream effect. *Promotes inflammation in arterial walls* - OxLDL does promote inflammation through multiple mechanisms (cytokine release, endothelial dysfunction). - However, this is a **secondary effect** that occurs after uptake and accumulation—not the primary reason for atherogenicity.

Q: What is the primary product of fatty acid oxidation (β-oxidation)?

Acetyl CoA. ***Acetyl CoA*** - Beta-oxidation of fatty acids involves a series of reactions that cleave two-carbon units from the fatty acyl chain, forming **acetyl CoA**. - **Acetyl CoA** is the direct product of each cycle of β-oxidation and then enters the **citric acid cycle** to generate ATP or serves as a precursor for other anabolic pathways. *Malonyl CoA* - **Malonyl CoA** is a key intermediate in **fatty acid synthesis**, not degradation. - It's formed from acetyl CoA by acetyl-CoA carboxylase and acts as a substrate for **fatty acid synthase**, and also as a physiological inhibitor of carnitine palmitoyltransferase I (CPT-I), thereby regulating β-oxidation. *Ketone bodies* - **Ketone bodies** (**acetoacetate** and **β-hydroxybutyrate**) are produced from acetyl CoA in the liver during conditions of low glucose availability or prolonged fasting. - They serve as an alternative fuel source for tissues like the brain and muscles, but are secondary products derived from the condensation of acetyl CoA molecules, not the primary direct product of fatty acid breakdown itself. *Cholesterol* - **Cholesterol** is a steroid lipid synthesized from **acetyl CoA** through a complex multi-step pathway (via HMG-CoA reductase pathway). - It is an important structural component of cell membranes and a precursor for steroid hormones and bile acids, but not a direct product of fatty acid catabolism.

Q: Where does omega oxidation of fatty acids occur?

Endoplasmic Reticulum. ***Endoplasmic Reticulum*** - **Omega oxidation** of fatty acids occurs in the **endoplasmic reticulum (microsomes)** of liver and kidney cells. - This pathway involves **hydroxylation of the terminal omega carbon** by **cytochrome P450 enzymes** located in the smooth ER. - The omega carbon is then oxidized to a **carboxyl group**, forming a **dicarboxylic acid**. - This is a **minor pathway** that becomes important when **beta-oxidation is impaired** or for metabolism of **medium-chain fatty acids**. *Cytosol* - The cytosol is involved in **fatty acid synthesis**, not omega oxidation. - While some later steps of fatty acid metabolism occur in the cytosol, the initial hydroxylation step of omega oxidation requires ER-localized cytochrome P450 enzymes. *Mitochondria* - **Mitochondria** are the primary site for **beta-oxidation** of fatty acids, not omega oxidation. - Beta-oxidation sequentially removes **two-carbon units from the carboxyl end**, which is distinct from omega oxidation. - The dicarboxylic acids produced by omega oxidation may subsequently undergo beta-oxidation in mitochondria. *None of the options* - This option is incorrect because the endoplasmic reticulum is the correct cellular location for omega oxidation. - The ER contains the necessary cytochrome P450 enzymes for the hydroxylation reaction that initiates this pathway.

Q: Which hormone inhibits hormone-sensitive lipase?

Insulin. ***Insulin*** - **Insulin** is a key anabolic hormone that promotes energy storage and inhibits catabolic processes, including the breakdown of triglycerides. - It directly inhibits **hormone-sensitive lipase (HSL)** activity, thus reducing the release of free fatty acids from adipose tissue. *Thyroid hormone* - **Thyroid hormones** (T3 and T4) generally promote catabolism and increase metabolic rate, including the mobilization of lipids. - They tend to **stimulate rather than inhibit** hormone-sensitive lipase expression and activity. *GH* - **Growth hormone (GH)** has lipolytic effects, meaning it promotes the breakdown of fats to provide energy. - GH typically **stimulates HSL activity** and increases the release of free fatty acids from adipocytes. *ACTH* - **Adrenocorticotropic hormone (ACTH)** primarily stimulates the adrenal cortex to produce cortisol. - **Cortisol** can have lipolytic effects in certain contexts and does not directly inhibit HSL; instead, catecholamines act as direct stimulators of HSL.

Question 1

Which of the following is an ω-6 fatty acid?

Accepted Answer

Linoleic acid

Answer

Cervonic acid

Answer

Alpha linolenic acid

Answer

Elaidic acid

Question 2

Enzyme deficient in Type I Hyperlipidemia?

Accepted Answer

Lipoprotein lipase

Answer

HMG CoA reductase

Answer

Peroxidase

Answer

Cholesterol acyl transferase

Question 3

Which of the following is monoenoic acid ?

Accepted Answer

Oleic acid

Answer

Linoleic acid

Answer

Linolenic acid

Answer

Arachidonic acid

Question 4

Which of the following is a true difference between gangliosides and cerebrosides?

Accepted Answer

Charge difference

Answer

Specific carbohydrate composition

Answer

Location in the nervous system

Answer

Presence of glucose

Question 5

Apo-E deficiency is seen in which of the following conditions?

Accepted Answer

Type III hyperlipoproteinemia

Answer

Type II hyperlipoproteinemia

Answer

Type I hyperlipoproteinemia

Answer

Type IV hyperlipoproteinemia

Question 6

Which molecule serves as the ultimate source of acetyl groups for fatty acid synthesis?

Accepted Answer

Acetyl CoA

Answer

Malonyl CoA

Answer

Palmitate

Answer

Citrate

Question 7

Why is oxidized LDL considered more atherogenic?

Accepted Answer

Is taken up by scavenger receptors

Answer

Is not recognized by LDL receptors

Answer

Promotes inflammation in arterial walls

Answer

Accumulates in macrophages

Question 8

What is the primary product of fatty acid oxidation (β-oxidation)?

Accepted Answer

Acetyl CoA

Answer

Malonyl CoA

Answer

Ketone bodies

Answer

Cholesterol

Question 9

Where does omega oxidation of fatty acids occur?

Accepted Answer

Endoplasmic Reticulum

Answer

Cytosol

Answer

Mitochondria

Answer

None of the options

Question 10

Which hormone inhibits hormone-sensitive lipase?

Accepted Answer

Insulin

Answer

GH

Answer

ACTH

Answer

Thyroid hormone

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?